My HPRA: Register

MAVENCLAD (PREVIOUSLY KNOWN CLADRIBINE MERCK)

10 Milligram Tablets

Merck Serono Europe LimitedEU/1/17/1212/001-006

Main Information

Trade NameMAVENCLAD (PREVIOUSLY KNOWN CLADRIBINE MERCK)
Active SubstancesCLADRIBINE
Strength10 Milligram
Dosage FormTablets
Licence HolderMerck Serono Europe Limited
Licence NumberEU/1/17/1212/001-006

Group Information

ATC CodeL01BB04 Purine analogues

Status

Authorised/WithdrawnAuthorised
Licence Issued22/08/2017
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print